Pre-Type 1 Diabetes Dysmetabolism: Maximal Sensitivity Achieved with Both Oral and Intravenous Glucose Tolerance Testing

Journal of Pediatrics

Volumn 150, Issue 1, 2007, Pages

  Barker, Jennifer M ^a   McFann, Kim ^a   Harrison, Leonard C ^a   Fourlanos, Spiros ^a   Krischer, Jeffrey ^a   Cuthbertson, David ^a   Chase, H Peter ^a   Eisenbarth, George S ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

EID: 33845634821     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.09.033     Document Type: Article

References (24)

1. Lendrum R., Walker G., and Gamble D.R. Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet 7912 (1975) 880-883
2. Bottazzo G.F., Dean B.M., Gorsuch A.N., Cudworth A.G., and Doniach D. Complement-fixing islet-cell antibodies in type I diabetes: possible monitors of active beta-cell damage. Lancet 8170 (1980) 668-672
3. Verge C.F., Stenger D., Bonifacio E., Colman P.G., Pilcher C., Bingley P.J., and Eisenbarth G.S. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 47 (1998) 1857-1866
4. Yu L., Robles D., Rewers M., Kaur P., Keleman K., and Eisenbarth G.S. High-throughput insulin autoantibody assay: 96 well filtration plate format. Diabetes 48 (1999) A213
5. Gardner S.G., Gale E.A., Williams A.J., Gillespie K.M., Lawrence K.E., Bottazzo G.F., et al. Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?. Diabetes Care 22 (1999) 2049-2054
6. Bruining G.J., Molenaar J.L., Grobbee D.E., Hoffman A., Scheffer G.J., Bruining H.A., et al. Ten-year follow-up study of islet-cell antibodies and childhood diabetes mellitus. Lancet 8647 (1989) 1100-1103
7. Bingley P.J., Christie M.R., Bonifacio E., Bonfanti R., Shattock M., Fonte M.-T., et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43 (1994) 1304-1310
8. Bingley P.J., Bonifacio E., Williams A.J.K., Genovese S., Bottazzo G.F., and Gale E.A.M. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46 (1997) 1701-1710
9. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Jackson R.A., et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45 (1996) 926-933
10. Chase H.P., Dolan L.M., Krischer J.P., White N., Wolfsdorf J.I., Cuthbertson D.D., et al., The DPT-1 Study Group. First phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes. J Pediatr 138 (2001) 244-249
11. Eisenbarth G.S., Gianani R., Yu L., Pietropaolo M., Verge C.F., Chase H.P., et al. Dual parameter model for prediction of type 1 diabetes mellitus. Proc Assoc Am Physicians 110 (1998) 126-135
12. Vardi P., Crisa L., Jackson R.A., Herskowitz R.D., Wolfsdorf J.I., Einhorn D., et al. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type I (insulin-dependent) diabetic patients. Diabetol 34 (1991) 93-102
13. Rosenbloom A.L., Hunt S.S., Rosenbloom E.K., and Maclaren N.K. Ten-year prognosis of impaired glucose tolerance in siblings of patients with insulin-dependent diabetes. Diabetes 31 (1982) 385-387
14. Greenbaum C.J., Cuthbertson D., and Krischer J.P. Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria. Diabetes 50 (2001) 470-476
15. Allen H.F., Jeffers B.W., Klingensmith G.J., and Chase H.P. First-phase insulin release in normal children. J Pediatr 123 (1993) 733-738
16. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 346 (2002) 1685-1691
17. Effects of oral insulin in relatives of patients with type I diabetes: the diabetes prevention trial-type 1. Diabetes Care 28 (2005) 1068-1076
18. Bingley P.J., Colman P., Eisenbarth G.S., Jackson R.A., McCulloch D.K., Riley W.J., et al. Standardization of IVGTT to predict IDDM. Diabetes Care 15 (1992) 1313-1316
19. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetol 28 (1985) 412-419
20. Greenbaum C.J. Insulin resistance in type 1 diabetes. Diabetes Metab Res Rev 18 (2002) 192-200
21. Fourlanos S., Narendran P., Byrnes G.B., Colman P.G., and Harrison L.C. Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetol 47 (2004) 1661-1667
22. Betts P., Mulligan J., Ward P., Smith B., and Wilkin T. Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the "accelerator hypothesis". Diabet.Med 22 (2005) 144-151
23. Daneman D. Is the "Accelerator Hypothesis" worthy of our attention?. Diabet Med 22 (2005) 115-117
24. Wilkin T.J. The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes. Diabetol 44 (2001) 914-922